In vitro biological validation and cytocompatibility evaluation of hydrogel iron-oxide nanoparticles
Journal article, Peer reviewed
MetadataShow full item record
Original versionCatalano, E. (2017, August). In vitro biological validation and cytocompatibility evaluation of hydrogel iron-oxide nanoparticles. In AIP Conference Proceedings (Vol. 1873, No. 1, p. 020011). AIP Publishing. https://doi.org/10.1063/1.4997140
Superparamagnetic iron oxide nanoparticles (MNPs) have recently been investigated for their excellent biocompatibility as well as multi-purpose biomedical potential with promising results, owing to their ability to be targeted and heated by magnetic fields. In this study, novel hydrogel, chitosan Fe3O4 magnetic nanoparticles were synthesized for possible use for induced magnetic hyperthermia, and targeted drug delivery. The coating of iron oxide nanoparticles plays a key-role to efficiently improve internalization of nanoparticles in many cell types. Targeting is also highly desirable for these applications. In this regard hydrophilic coating like chitosan was used to improve drug release. Uncoated (Fe3O4)and chitosan-coated iron oxide nanoparticles (CS-Fe3O4) were synthesized and characterized from the biological point of view. The aim of this study was to provide an in vitro evaluation of the cytocompatibility of Fe3O4 and CS-Fe3O4 MNPs by using different in vitro evaluation tests. In this context, the cytocompatibility and cytotoxic effects of uncoated and hydrogel chemically-engineered chitosan-coated iron oxide NPs were investigated according to the ISO standard 10993-5:2009. Fe3O4 and CS-Fe3O4 NPs were tested on human mammary epithelial cells (MCF-10A) by using direct and not direct contact cytotoxicity evaluation tests, by evaluating influence of the iron particles on the cytoskeleton with phalloidin/DAPI staining and in vitro cellular iron uptake with Perl’s Prussian blue staining. The results indicate that uncoated and chitosan-coated iron oxide nanoparticles are cytocompatible, without negative influence on the cytoskeleton or higher accumulation of iron in the cytoplasm. Therefore, it is encouraging that our data suggest uncoated and chitosan-coated iron oxide nanoparticles have satisfactory proliferative and viability effects on MCF-10A cells. In conclusion data suggest that both MNP types may be differently aimed in biomedical application in relation to the dose, acting as biocompatible materials, as component of scaffolds, or as a device for theranostics.